Suppr超能文献

骨筋膜室综合征合并遗传性出血性疾病患者的治疗考量

Treatment of considerations in patients with compartment syndrome and an inherited bleeding disorder.

作者信息

Naranja R J, Chan P S, High K, Esterhai J L, Heppenstall R B

机构信息

Department of Orthopedics, University of Pennsylvania, Philadelphia 19104, USA.

出版信息

Orthopedics. 1997 Aug;20(8):706-9; quiz 710-1. doi: 10.3928/0147-7447-19970801-10.

Abstract

In addition to consultation with an experienced hematologist, the following are recommendations regarding compartment syndrome in a patient with an inherited bleeding disorder. Von Willebrand's Disease. Humate-P (rich in von Willebrand factor) is the replacement therapy of choice for surgical procedures in patients with von Willebrand's disease. In general, in the perioperative period, factor VIII levels between 50% and 100% are ideal with a gradual tapering to maintain levels at 50% for approximately 2 weeks. Adjuncts to therapy are DDAVP and EACA. Hemophilia A. During the initial evaluation and with measurement of compartment pressures, factor VIII replacement to levels in the range of 40% to 60% of normal is appropriate replacement therapy. For fasciotomy, however, factor VIII levels greater than 50% to 100% are required. In patients who have developed antibodies to factor VIII, a number of options are available. With low titers of factor VIII inhibitor, higher doses of factor VIII may be successful in overriding the inhibitor. In patients with higher titers of inhibitor, activated factor VII or porcine factor VIII is recommended. Hemophilia B. Highly purified factor IX replacement aimed at keeping factor levels between 50% and 100% in the perioperative period, followed by maintenance at 50% for approximately 2 weeks, is optimal management. Treatment Algorithm: The Figure outlines an algorithm to aid in the diagnosis and treatment of compartment syndrome in the patient with an inherited bleeding disorder. In a suspected case of compartment syndrome due to a soft-tissue hemorrhage or injury, factor replacement as outlined above should be initiated. Unequivocal clinical findings in the normal patient usually would be an indication to proceed to fasciotomy without obtaining compartment pressures. In the patient with an inherited bleeding disorder, however, factor replacement and subsequent normalization of the clotting cascade may help lowe compartment pressures. Therefore, we advocate obtaining initial pressures even with clinical findings of an acute compartment syndrome. At our institution, we advocate using an automated handheld pressure monitor (Stryker, Ontario, Canada) or the needle injection technique as described by Whitesides et al. In interpreting the obtained pressures, we choose to use the guidelines as described by Heppenstall et al. Briefly, Heppenstall et al determined that the pressure threshold at which cellular damage occurred was related more closely to the difference between the mean arterial blood pressure and compartment pressure than with the absolute compartment pressure alone; this measurement is called delta P. If delta P is > 30 mm Hg, then one should continue factor replacements and perform serial clinical and pressure examinations. Pressures should be taken every hour for 2 hours total. If the patient worsens in either respect, then the physician should enter the other limb of the algorithm for delta P < 30 mm Hg. For the patient with a delta P < 30 mm Hg, the amount of time since onset of symptoms must be considered. Since the patient may improve with adequate factor replacement, a delta P < 30 mm Hg mercury does not dictate automatic fasciotomy. An adequate time trial of replacement therapy may be attempted. In patients whose pressures do not begin normalizing, we advocate proceeding to fasciotomy. Patients who begin to normalize pressures during a 2-hour trial can be followed with serial clinical and pressure examinations. Any worsening in either scenario is an indication for fasciotomy; otherwise, observation and factor replacement may be continued. After initial decompression, staples may be placed in both wound edges with an elastic vascular loop woven between the two edges in a "shoelace" pattern. Then while waiting for closure, the loops can be gradually tightened at the bedside. Definitive closure should be attempted around the fifth postoperative day. All closure techniques should be pre

摘要

除了咨询经验丰富的血液科医生外,以下是关于遗传性出血性疾病患者骨筋膜室综合征的建议。血管性血友病。Humate - P(富含血管性血友病因子)是血管性血友病患者手术的首选替代疗法。一般来说,在围手术期,凝血因子 VIII 水平维持在 50%至 100%较为理想,之后逐渐减量,使水平维持在 50%左右约 2 周。治疗辅助药物有去氨加压素(DDAVP)和 6 - 氨基己酸(EACA)。甲型血友病。在初始评估及测量骨筋膜室压力时,将凝血因子 VIII 替代至正常水平的 40%至 60%是合适的替代疗法。然而,对于筋膜切开术,凝血因子 VIII 水平需高于 50%至 100%。对于已产生抗凝血因子 VIII 抗体的患者,有多种选择。抗凝血因子 VIII 抑制剂滴度较低时,较高剂量的凝血因子 VIII 可能成功克服抑制剂作用。抑制剂滴度较高的患者,推荐使用活化凝血因子 VII 或猪源性凝血因子 VIII。乙型血友病。围手术期以高度纯化的凝血因子 IX 替代,使因子水平维持在 50%至 100%,之后维持在 50%约 2 周,是最佳治疗方案。治疗算法:图中概述了一种算法,以帮助诊断和治疗遗传性出血性疾病患者的骨筋膜室综合征。在怀疑因软组织出血或损伤导致骨筋膜室综合征的情况下,应启动上述凝血因子替代治疗。正常患者明确的临床体征通常表明应进行筋膜切开术,而无需测量骨筋膜室压力。然而,对于遗传性出血性疾病患者,凝血因子替代及随后凝血级联反应的正常化可能有助于降低骨筋膜室压力。因此,即使有急性骨筋膜室综合征的临床体征,我们也主张测量初始压力。在我们机构,我们主张使用自动手持式压力监测仪(史赛克公司,加拿大安大略省)或采用 Whitesides 等人描述的针注射技术。在解读所测压力时,我们选择采用 Heppenstall 等人描述的指南。简而言之,Heppenstall 等人确定细胞损伤发生时的压力阈值与平均动脉血压和骨筋膜室压力之差的关系比仅与绝对骨筋膜室压力的关系更为密切;该测量值称为 ΔP。如果 ΔP>30 mmHg,则应继续凝血因子替代治疗,并进行系列临床和压力检查。总共应每小时测量一次压力,持续 2 小时。如果患者在任何一方面病情恶化,医生应进入算法中 ΔP<30 mmHg 的另一分支。对于 ΔP<30 mmHg 的患者,必须考虑症状出现后的时间。由于患者可能通过充分的凝血因子替代治疗而好转,ΔP<30 mmHg 并不意味着必须立即进行筋膜切开术。可尝试进行足够时间的替代治疗试验。对于压力未开始恢复正常的患者,我们主张进行筋膜切开术。在 2 小时试验期间压力开始恢复正常的患者,可进行系列临床和压力检查进行随访。在任何一种情况下病情恶化均表明需进行筋膜切开术;否则,可继续观察和凝血因子替代治疗。初始减压后,可在伤口两侧边缘放置缝钉,用弹性血管环以“鞋带”模式编织在两侧边缘之间。然后在等待伤口闭合期间,可在床边逐渐收紧血管环。应尝试在术后第 5 天左右进行确定性缝合。所有缝合技术均应预先……

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验